RETURNING GENETIC RESEARCH RESULTS TO INDIVIDUALS: POINTS‐TO‐CONSIDER
Gaile Renegar(GlaxoSmithKline (Spain)), C. Brazell(GlaxoSmithKline (Germany)), Chris Webster(Leeds Beckett University), BETH BALKITE(GlaxoSmithKline (Spain)), Taryn Rogalski-Salter(Merck & Co., Inc., Rahway, NJ, USA (United States)), Steffen Stuerzebecher, Diane Barnes(Abbott Fund), Brian B. Spear(Abbott Fund), Susan Ide(Novartis (United States)), Nadine Cohen(Technion – Israel Institute of Technology), Lea C. Harty(Pfizer (United States))
Cited by 94
Related Papers
Mapping of a Gene for Parkinson's Disease to Chromosome 4q21-q23
|Science|1996|784
The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA
|Nature Genetics|2001|584
Mutations in a new gene in Ellis-van Creveld syndrome and Weyers acrodental dysostosis
|Nature Genetics|2000|358
Pharmacogenetics and Pharmacogenomics in Drug Development and Regulatory Decision Making: Report of the First FDA‐PWG‐PhRMA‐DruSafe Workshop
|The Journal of Clinical Pharmacology|2003|123